Nanobiotix【0QAV】銘柄情報

Nanobiotix (0QAV) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

6.3825

( - )

買値

6.225

売値

6.54

出来高

3,660

0.00 日の範囲 0.00

6.3825 52 週間の範囲 6.3825

時価総額

323.682M

前日終値

6.3825

始値

時刻

30.56

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

245,483 €

発行済株式数

50,713,979

配当利回り

PER

-60.51

1 株当たり利益 (EPS)

-0.5

歳入

32.59M

純利益

-23.96M

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of ... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France. 詳細を表示

セクター

業界

ウェブサイト

www.nanobiotix.com

本社

Paris, France

設立

2026

Nanobiotix is listed in the sector of the ロンドン証券取引所 with ticker 0QAV. The last closing price for Nanobiotix was 6.38 €. Over the last year, Nanobiotix shares have traded in a share price range of 6.3825 € to 6.3825 €.

Nanobiotix currently has 50,713,979 shares in issue. The market capitalisation of Nanobiotix is 323.68 € million. Nanobiotix has a price to earnings ratio (PE ratio) of -60.51.

Voting Rights and Shares Capital of the Company

Voting Rights and Shares Capital of the Company In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General...

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Conformément aux articles L.233-8 II du...

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

Nanobiotix Provides First Quarter 2026 Operational and Financial Update Completed a follow-on offering in May 2026 for aggregate gross proceeds of...

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026

Nanobiotix fait le point sur sa tresorerie et son activite operationnelle pour le premier trimestre 2026 Réalisation d’une augmentation de capital...

Nanobiotix Joins the Euronext Tech Leaders Index

Nanobiotix Joins the Euronext Tech Leaders Index PARIS and CAMBRIDGE, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO...

Nanobiotix rejoint l'indice Euronext Tech Leaders

Nanobiotix rejoint l'indice Euronext Tech Leaders PARIS et CAMBRIDGE, Mass., 02 juin 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –...

NANOBIOTIX annonce le règlement-livraison de son offre globale

NANOBIOTIX annonce le règlement-livraison de son offre globale PARIS and CAMBRIDGE, Mass., 26 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX...

NANOBIOTIX Announces Closing of Global Offering

NANOBIOTIX Announces Closing of Global Offering PARIS and CAMBRIDGE, Mass., May 26, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –...

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million PARIS...

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars

NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars PARIS et...

期間 †	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	DE
4	0	0	0	0	0	DE
12	0	0	0	0	0	DE
26	6.3825	6.3825	6.3825	11781	6.3825	DE
52	6.3825	6.3825	6.3825	19316	6.3825	DE
156	6.3825	6.3825	6.3825	9823	6.3825	DE
260	6.3825	6.3825	6.3825	7432	6.3825	DE